Skip to content

PANCHATHIKTA KIRUTHAM (INTERNAL)AND KARUNKOZHI THYLAM (EXTERNAL) IN RHEUMATOID ARTHRITIS

CLINICAL EVALUATION OF PANCHATHIKTA KIRUTHAM (INTERNAL MEDICINE) AND KARUNKOZHI THYLAM (EXTERNAL MEDICINE) IN THE MANAGEMENT OF UTHIRAVATHA SURONITHAM (RHEUMATOID ARTHRITIS)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036341
Enrollment
30
Registered
2021-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Drug-Panchathikta kirutham (internal) Drug- Karunkozhi thylam(external) : Drug(internal)-Panchathikta kirutham Dosage-Kaal palam (8.5gm) Duration- 45 days Drug(external) Karunkozhi

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age : 20 years-50 years Sex: Male ,female and transgender Insidious onset of Polyarthritis in the joints. Prolonged morning stiffness (for 6 weeks or more) Swelling of multiple joints involved for 6 weeks or more. Slow progressive signs of inflammation of joints. E.g. Pain, tenderness, warmth >6 weeks Symmetrical joint involvement Swelling especially in interphalangeal joints. Rheumatoid factor positive or negative. Patients who are willing to attend OPD or willing for admission IPD. Patients who are willing to undergo Radiological investigation and other laboratory investigation. Patient who are willing to sign the informed consent stating that he/ she will consciously stick to the treatment during 48 days but can stop opt out of the trail of his /her own conscious discretion.

Exclusion criteria

Exclusion criteria: Pregnancy and lactating mother Diabetes mellitus History of trauma Any other arthritis Any other serious systemic illness like Cancer, Cardiac disease. Systemic complication of Rheumatoid arthritis. Characteristic deformities of hands and feet in Rheumatoid arthritis. (Z ââ?¬â??deformity, Boutonniere deformity, Swan neck deformity in hands, Hammer toe)

Design outcomes

Primary

MeasureTime frame
Assessment of pain will be done by Universal pain assessment scale and other clinical signs and symptoms will be assessed by Gradation methodTimepoint: 12 months

Secondary

MeasureTime frame
Laboratory investigations such as RA factor, ESR, CRP, ASO titre, Anti CCP will be assessed before and after treatment. Secondary outcome will be assessed by comparing the parameters pre and post treatment Envagaithervu, Neikuri and neerkuri , Udal thadhukkal, Uyirthadhukkal, Kaalam etc, in Uthiravatha suronitham patients. Timepoint: 12 months

Countries

India

Contacts

Public ContactDr S Mahespriya

National Institute of Siddha

dr.vetha@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026